"Automated Endoscope Reprocessors (AER) Market to Exhibit Profitable Growth during the Forecast Period"

The global automated endoscope reprocessors market accounted for market value of US$ 364.2 Mn in 2017 and expected to attain US$ 554.4 Mn by 2026. Worldwide growing endoscopy and minimally invasive surgical procedures coupled with increasing prevalence of infectious diseases drives the overall market growth during the forecast period. In addition, technological developments in automated endoscope reprocessors and the presence of favorable private and public initiatives across various developing countries will further assist in the overall AER market growth.

Around 20 million gastrointestinal endoscopic procedures are performed every year in the U.S. Transmission of infection by endoscopes is rare, but still happening with an expected recurrence of 1 out of every 1.8 million endoscopy procedures in the United States. However, infection control mechanisms might be miscalculated on account of incomplete sterilization, improper follow up of FDA guidelines, and asymptomatic contaminations during transfer, along with contaminations with a long incubation cycle. Top AERs approved in the U.S. are EvoTech ECR (Advanced Sterilization Products), Medivators DSD-201LT, Medivators DSD Edge, Medivators Advantage Plus PLUS Pass-Thru AER, ENDOCLENS-NSX AER and others. Manufacturers are now more focused on elevating the flexible endoscope reprocessing standards. Government bodies have also implemented various guidelines that follow a single pathway, or one-way channel that surveys this circular lifecycle of endoscope reprocessing and lessens the risk of errors while handling or transfer and cross-contamination in the hospitals.

Technological developments in automated endoscope reprocessors are boosting the demand in North America and Western Europe. Transportable or portable AER machines are gaining higher momentum among clinics and hospitals. The ADVANTAGE PLUS Pass-Thru AER has also been implemented for further reprocessing of endoscopes in other parts of world such as Canada, Western Europe, Australia and parts of the U.S., offering the most technologically advanced methodologies in a simpler way to reprocess.

"The Portable AER Machines Segment is expected to Register Higher Growth by the End of 2026"

Transportable or portable AERs are gaining traction across the globe and majorly used at hospitals. Rapid launch of portable, cost-effective, and easy-to-use automated endoscope reprocessors are likely to witness faster adoption among the end users as compared to high-end standalone devices. Transportable or portable AER machines offer faster and uninterrupted care to patients; offer an exceptional protocol integrating speed, expediency and protection for ENT endoscopes, bronchoscopes and cystoscopes. For e.g. Serie ENT AER machine (manufactured by Soluscope) reprocess the endoscopes in less than 15 minutes, cleans and disinfects up to 4 endoscopes in less than 1 hour. With the low cost pricing strategy with compact design, faster reprocessing cycle, high-end technology, and efficient workflow coupled with higher patient safety, manufacturers are offering and expanding their products in the Asia Pacific and Europe to acquire more market share. Newly manufactured and FDA approved AER machines improve adherence to conventional manufacturing guidelines for disinfection process and have been clinically proven to reprocess universally utilized endoscopes while reprocessing.

"On the Basis of Modality, Standalone AER Segment is Forecast to Command the Market by the End of 2026"

Standalone automated endoscope reprocessors are consolidations of HLD (high level disinfectants) solutions, sensors, automatic leak testing, drying and digital electronics with sophisticated data processing algorithms in order to provide high accuracy that is propelling the adoption of automated endoscope reprocessors. Owing to a surge in the endoscopy procedures across world to replace the manual cleaning processes, the adoption of standalone AER machines is on the rise and expected to continue the dominance over the forecast period.

"Hospitals & Clinics Segment Contribute Maximum to the Overall Growth of Automated Endoscope Reprocessors Market"

Increasing number of endoscopy procedures, ambulatory surgical centers & clinics coupled with comparatively higher adoption of automated endoscope reprocessors during the endoscopy procedures is supporting the dominance of AERs in the hospitals segment for higher infection control and patient safety. Additionally, increasing instances of cross-contamination in hospitals & clinics along with rising number of hospital acquired infection rates may increase the demand of AER machines in the developing nations.

"Rising Cases for Endoscopy and Minimally Invasive Procedures and the Presence of Favorable Reimbursement Policies Holds North America in Dominant Position"

North America spearheaded the market in 2017 owing to the presence of favorable reimbursement policies in the U.S., coupled with increasing GI endoscopy procedures and adoption of top-end advanced AER machines for better quality control and measurement. Also, growing concerns about patient safety among clinicians, increasing ageing population, and development of novel automated endoscope reprocessors is driving the growth of the AER market during the forecast period in North America. Asia Pacific expected to register comparatively higher CAGR over the forecast period due to rising number of endoscopy admissions and growing awareness among the end users about newly manufactured automated endoscope reprocessing machines.

"Dominance of Established Multinational Players with Strong Product Portfolio Makes Market Penetration Difficult For Emerging Players"

Major players in this space are Medivators, Advanced Sterilization Products (Johnson & Johnson), Arc Healthcare Solutions, Bes Decon (A Division of Bes Rehab Ltd), Cantel Medical, Custom Ultrasonics, Endo-Technik W. Griesat, Getinge, Laboratories Anios (A Subsidiary of Ecolab Inc.), Metrex Research, Olympus, Steelco, Steris, Wassenburg Medical (A Member of Hoya) and others. These market participants are adopting growth strategies such as new product launches, mergers & acquisitions, partnerships, and collaborations to gain a competitive advantage. For instance, in June 2018, in the U.S., Hennepin Healthcare Clinic installed the first pass through AER machine manufactured by Medivators (ADVANTAGE PLUS Pass-Thru AER). The overall approach totally reforms the endoscope reprocessing room, lifting the procedure from meeting least principles to accomplishing best practices.

Historical & Forecast Period

This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

Automated endoscope reprocessors market comprises current market trends and dynamics along with quantitative analysis of the global market. The report elucidates thorough information of global automated endoscope reprocessors market by segmenting the market in terms of product, modality, end-use, and geography. This report would guide healthcare professionals and market players in decision-making and strategizing market position.

The current report includes qualitative market assessment factors such as market drivers, restrains, opportunities, current and future market trends which gives better understanding of the overall automated endoscope reprocessors market. Furthermore, the report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths. Key industrial players profiled in the study report are Medivators, Advanced Sterilization Products (A Johnson & Johnson Company), Arc Healthcare Solutions, Bes Decon (A Division of Bes Rehab Ltd), Cantel Medical, Custom Ultrasonics, Endo-Technik W. Griesat, Getinge, Laboratories Anios (subsidiary of Ecolab Inc.), Metrex Research, Olympus, Steelco, Steris, Wassenburg Medical (A Member of Hoya) and others.

Key questions answered in this report

• What are the current market trends and dynamics in the automated endoscope reprocessors market and valuable opportunities for emerging players?
• Market positioning of major key players operating in the market?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which modality type held the major market share in 2017?
• Which end-user holds a larger market share and why?
• What is the impact of high cost devices on the automated endoscope reprocessors market?
• Are low and middle-income economies investing in the automated endoscope reprocessors market?
• What is the market trend and dynamics in emerging markets such as Japan, Latin America and Middle East & Africa?